Bollinger Innovations Files 8-K on Delisting, Bylaws, and Financials

TL;DR

Bollinger Innovations (MULN) filed an 8-K detailing delisting concerns, bylaw changes, and financial updates as of 9/30/25.

AI Summary

Bollinger Innovations, Inc. filed an 8-K on October 10, 2025, reporting on several key events. These include a notice of delisting or failure to meet continued listing standards, amendments to its articles of incorporation or bylaws, and a Regulation FD disclosure. The filing also covers financial statements and exhibits, with the period of report ending September 30, 2025.

Why It Matters

This 8-K filing signals potential issues with Bollinger Innovations' continued listing on an exchange and updates on corporate governance and financial reporting.

Risk Assessment

Risk Level: high — The filing explicitly mentions a notice of delisting or failure to satisfy continued listing rules, indicating significant financial or operational distress.

Key Numbers

• 20250930 — Period of Report End Date (Indicates the financial and operational period covered by the filing.)
• 20251010 — Filing Date (The date the 8-K was officially submitted to the SEC.)

Key Players & Entities

• BOLLINGER INNOVATIONS, INC. (company) — Filer
• MULN (company) — Ticker Symbol
• MULLEN AUTOMOTIVE INC. (company) — Former Company Name
• Net Element, Inc. (company) — Former Company Name
• Net Element International, Inc. (company) — Former Company Name

FAQ

Key Financial Figures

• $0.001 B — ch registered Common Stock, par value $0.001 BINI The Nasdaq Stock Market, LLC (Nasd
• $35.0 million — Securities (" MVLS ") was less than the $35.0 million minimum required for continued listing
• $0.001 — Convertible Preferred Stock, par value $0.001 per share, from 30,335 to 103,539, amen

Filing Documents

• bollingerinnovations_8k.htm (8-K) — 43KB
• bollingerinnovations_ex3-1.htm (EX-3.1) — 14KB
• bollingerinnovations_ex3-2.htm (EX-3.2) — 9KB
• bollingerinnovations_ex99-1.htm (EX-99.1) — 19KB
• ex99-1_001.jpg (GRAPHIC) — 4KB
• 0001829126-25-008053.txt ( ) — 311KB
• muln-20250930.xsd (EX-101.SCH) — 4KB
• muln-20250930_def.xml (EX-101.DEF) — 26KB
• muln-20250930_lab.xml (EX-101.LAB) — 36KB
• muln-20250930_pre.xml (EX-101.PRE) — 25KB
• bollingerinnovations_8k_htm.xml (XML) — 6KB

01

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 8, 2025, Bollinger Innovations, Inc. (the " Company ") received written notification from the Listing Qualifications Staff (the " Staff ") of The Nasdaq Stock Market LLC (" Nasdaq ") that trading in the Company's securities will be suspended at the open of trading on Monday, October 13, 2025. On February 25, 2025, as previously disclosed in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the " SEC ") on February 28, 2025, the Company received a written notice from the Staff notifying the Company that its Market Value of Listed Securities (" MVLS ") was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the " MVLS Listing Rule "). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until August 25, 2025 (the " Compliance Period "), to regain compliance with the MVLS Listing Rule. On August 26, 2025, as previously disclosed in a Current Report on Form 8-K filed with the SEC on August 29, 2025, the Company received a written notice from the Staff stating that the Company had not regained compliance with the MVLS Listing Rule within the Compliance Period. The Company timely requested a hearing to appeal the Staff's delist determination before a Hearings Panel, which automatically stayed any suspension or delisting action. However, the Company subsequently withdrew its request for a hearing, and, as a result, the Company received written notification from the Staff that trading in the Company's securities will be suspended on Monday, October 13, 2025. Nasdaq will also file a Form 25 Notification of Delisting with the SEC when all internal procedural periods have run. Effective Monday, October 13, 2025, the Company's common stock will commence trading on the OTCID market of th

03

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 30, 2025, the Company filed Certificates of Amendment with the Secretary of State of the State of Delaware (each a " Certificate of Amendment " and together, the " Certificates of Amendment "), amending each of the Certificate of Designations, Preferences and Rights of Series F Convertible Preferred Stock (the " Series F Certificate of Designations ") and the Certificate of Designations, Preferences and Rights of Series G Convertible Preferred Stock (the " Series G Certificate of Designations " and, together with the Series F Certificate of Designations, the " Certificates of Designations "), which were originally filed with the Delaware Secretary of State on July 29, 2025, as previously reported in the Company's Current Report on Form 8-K, filed with the SEC on July 31, 2025, and Quarterly Report on Form 10-Q/A (Amendment No. 1), filed with the SEC on August 16, 2025. The Certificates of Amendment became effective upon filing. The Certificate of Amendment to the Series F Certificate of Designations increased the number of authorized shares of Series F Convertible Preferred Stock, par value $0.001 per share, from 30,335 to 103,539, amended the definition of "Exchange Agreement" and created three new serial designations of Series F Preferred Stock. The Certificate of Amendment to the Series G Certificate of Designations increased the number of authorized shares of Series G Convertible Preferred Stock, par value $0.001 per share, from 116,365 to 126,460 and amended the definition of "Exchange Agreement".

01

Item 7.01 Regulation FD Disclosure. On October 9, 2025, the Company issued a press release announcing its move to the OTC Markets. This press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. 1

Forward-Looking Statements

Forward-Looking Statements Certain statements in this Current Report on Form 8-K that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in herein that are not statements of historical fact may be deemed forward-looking statements. Words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential" and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Bollinger Innovations and are difficult to predict. Examples of such risks and uncertainties include but are not limited to whether the Company will satisfy the listing qualifications of another market of the OTC Markets; what impact the move from Nasdaq to the OTC Markets will have on the Company; that there is no guarantee that brokers will continue to make a market in the Company's common stock or that trading thereof will continue on the OTC Markets or otherwise; expected timing of the change of the listing of the common stock from Nasdaq to the OTC Markets; the potential benefits to be realized by the transfer of its listing to the OTC Markets and whether eliminating the effort and cost required to maintain compliance with Nasdaq's continued listing standards will better enable it to currently focus on its business strategy; and whether the Company will satisfy the listing criteria and be approved for trading on an international stock exchange or be able return to a U.S. national exchange in the future. Additional examples of such risks and uncertainties include but are not limited to: (i) Bollinger Innovations' ability (or inability) to

Financial Statements

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 3.1 Certificate of Amendment to Certificate of Designations, Preferences and Rights of Series F Preferred Stock, filed September 30, 2025. 3.2 Certificate of Amendment to Certificate of Designations, Preferences and Rights of Series G Preferred Stock, filed September 30, 2025. 99.1 Press Release issued on October 9, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. BOLLINGER INNOVATIONS, INC. Date: October 10, 2025 By: /s/ David Michery David Michery Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR